In this episode, Howard, Bill, Kristan, and a new guest Dr. Jeff Maki discuss Body MRI.
- Describe the differences between the ACR and FDA’s stance on screening for renal disease prior to the administration of a GBCA
- State the FDA policy on the distribution of the medication guide for a GBCA
- List the main clinical uses for GBCAs in liver imaging
- State the two main types of contrast agents used for MRI of the liver
- State the benefits of DWI in liver and body imaging
- Describe strategies for breath-holding in abdominal MR exams
- Name benefits of SPIO agents in body imaging
The content of this Contrast Enhanced MRI Program is intended for healthcare professionals who work in the MRI environment. These individuals include MRI Technologists, Imaging Nurses, MRI Researchers, and Others.
This program has been submitted for 1.00 hour of Category A CE credit as designated by the International Society for MR Radiographers and Technologists (ISMRT) RCEEM.
Release Date: 02/28/2023 | Expires: 03/01/2024
Faculty and Planner Disclosures: In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME/CE activity. The planner has nothing to disclose
This MRiCast episode is supported by Bracco Diagnostics Inc. through an unrestricted educational grant.